TIFAB anticorps (Middle Region)
Aperçu rapide pour TIFAB anticorps (Middle Region) (ABIN955210)
Antigène
Voir toutes TIFAB AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 40-70, Middle Region
-
Specificité
- This antibody detects TIFAB (Center).
-
Réactivité croisée (Details)
- Species reactivity (tested):Human, mouse
-
Purification
- Protein A column followed by peptide affinity purification
-
Immunogène
- KLH conjugated synthetic peptide between 40-70 amino acids from the Central region of human TIFAB
-
Isotype
- Ig Fraction
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.25 mg/mL
-
Buffer
- PBS with 0.09 % (W/V) sodium azide
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Avoid repeated freezing and thawing.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 2 - 8 °C for up to six months or (in aliquots) at -20 °C for longer.
-
-
- TIFAB (TRAF-Interacting Protein with Forkhead-Associated Domain, Family Member B (TIFAB))
-
Autre désignation
- TIFAB
-
Sujet
- TIFAB associates with TIFA (MIM 609028) and inhibits TIFA-mediated activation of NF-kappa-B (NFKB1, MIM 164011) (Matsumura et al., 2004 [PubMed 15047173]).Synonyms: TRAF-interacting protein with FHA domain-containing protein B
-
ID gène
- 497189
-
NCBI Accession
- NP_001092691
Antigène
-